Sunday 5th February, 2012   |   Welcome, guest. Please, login or register  
Thursday November 19, 11:40

A patch therapy against hay fever

A patch therapy against allergic rhinitis (hay fever) can ease suffering in affected people
A patch therapy against allergic rhinitis (hay fever) can ease suffering in affected people
 

Even if the subject is not entirely valid in the middle of autumn, the information will be of interest to all those who still fear the return of spring.

A patch therapy against hay fever (epicutaneous immunotherapy) may soon alleviate their problems. This is indicated by an experiment and its first results that have just been published in the Journal of Allergy and Clinical Immunology.

Team of Gabriela Senti at the University Hospital of Zurich, conducted a study on 37 adults sensitive to grass pollen with skin and nasal testing to provoke a hay fever reaction.

Patients received a patch containing either the allergen (21) or placebo (16), put on the upper arm for 48 hours once a week for three months.

The patch, developed and produced by the University Hospital of Zurich, was a sheet of polyethylene filled with pollen extract of Phleum pratense measured at 300 IR (index of reactivity) in vaseline, or a placebo.

The plate was perforated on the skin side and held by adhesive tape. Allergen group patients showed greater tolerance to nasal provocation test for at least a year. The first year, this improvement was not very different from that observed in the placebo group, but the placebo effect disappeared in the second season, while the improvement persisted in the treated group.

Patients who received the "true" patch also reported improvement of symptoms of hay fever significantly higher during the two years of treatment than the placebo group compared to the year before treatment.

The use of drugs against hay fever was similar in both groups, showing that patients continued to have symptoms of hay fever, but they were better controlled in the allergen group, say the authors.

 
Rate:
  •  
Please, login to rate the article.
 
 

Recommended articles:

 

An H1N1 vaccine as nasal spray in the U.S.

Vaccination against the H1N1 virus, based on FluMist, at a school in Miami (Florida)
FluMist is well accepted overseas, but has not been approved in Europe yet.
 

New survey on spray to delay ejaculation

It appears that the time of intercourse for 90% of men using PSD502 increased from a few seconds to at least four minutes
This product is designed for men suffering from premature ejaculation. Men with premature ejaculation problems have multiplied the time of intercourse by six with the PSD502 (Premature Ejaculation Spray).
 

Parkinson: a promising triple gene therapy

According to the neurosurgeon, the injection of therapeutic genes in the striatum, which is done under general anesthesia, is technically easier than the implantation of stimulation electrodes in the subthalamic nucleus.
 

Most recent in the category Human body:

 
 
 

Last comments

 

No comments. Be the first to comment the article!

Please, login to post comments.
 
 
 
 

Home | Social Health | AIDS | Cancer | Deseases | Diet | Human body | Most read | Top rated

RSS | Feedback | Headlines for your website | Terms of Service/Privacy policy

Copyright © 2012 Heal-all.org. All rights reserved.